Myomo (MYO) Income from Continuing Operations (2016 - 2025)
Myomo's (MYO) quarterly Income from Continuing Operations came in at 3662915.0 in Q3 2025, down 279.02% YoY from 2046055.23 in Q3 2024, and up 20.92% on a QoQ basis from 4631972.0 in Q2 2025.
Myomo (MYO) Income from Continuing Operations (2016 - 2025) Analysis & Trends
Myomo (MYO) has 10 years of Income from Continuing Operations data on file, last reported at 3662915.0 in Q3 2025.
- Quarterly Income from Continuing Operations fell 279.02% year-over-year to 3662915.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 13026685.0 (down 43.01% YoY) and the FY2024 annual result came in at 7190388.0, up 18.96% from the prior year.
- Income from Continuing Operations grew to 3662915.0 in Q3 2025, from 4631972.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 966409.0 in Q3 2024 to a low of 4631972.0 in Q2 2025.
- A 5-year average of 2595181.05 and a median of 2814934.0 in 2022 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2023 — Income from Continuing Operations surged 65.14% — and 2025, when it plunged 312.98%.
- Tracing MYO's Income from Continuing Operations over 5 years: stood at 2944490.0 in 2021, then grew by 20.25% to 2348161.0 in 2022, then sank by 35.65% to 3185292.0 in 2023, then surged by 60.23% to 1266740.0 in 2024, then slumped by 189.16% to 3662915.0 in 2025.
- The last three Income from Continuing Operations figures came in at 3662915.0 (Q3 2025), 4631972.0 (Q2 2025), and 3465058.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Myomo | 72.95 Mn | 53.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -3.66 Mn |
| Jun 30, 2025 | -4.63 Mn |
| Mar 31, 2025 | -3.47 Mn |
| Dec 31, 2024 | -1.27 Mn |
| Sep 30, 2024 | -966,409.00 |
| Jun 30, 2024 | -1.12 Mn |
| Mar 31, 2024 | -3.84 Mn |
| Dec 31, 2023 | -3.19 Mn |
| Sep 30, 2023 | -2.03 Mn |
| Jun 30, 2023 | -1.01 Mn |
| Mar 31, 2023 | -2.64 Mn |
| Dec 31, 2022 | -2.35 Mn |
| Sep 30, 2022 | -2.83 Mn |
| Jun 30, 2022 | -2.91 Mn |
| Mar 31, 2022 | -2.81 Mn |
| Dec 31, 2021 | -2.94 Mn |
| Sep 30, 2021 | -2.06 Mn |
| Jun 30, 2021 | -2.62 Mn |
| Mar 31, 2021 | -2.96 Mn |
| Dec 31, 2020 | -1.70 Mn |